Trials / Sponsors / Carl Ola Landgren, MD, PhD
Carl Ola Landgren, MD, PhD
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase Multiple Myeloma | Phase 2 | 2023-12-04 |